Search

Your search keyword '"de Hingh, I. H. J. T."' showing total 288 results
Start Over Author "de Hingh, I. H. J. T."
288 results on '"de Hingh, I. H. J. T."'

1. Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study

Author

van Goor, I. W. J. M., Andel, P. C. M., Buijs, F. S., Besselink, M. G., Bonsing, B. A., Bosscha, K., Busch, O. R., Cirkel, G. A., van Dam, R. M., Festen, S., Koerkamp, B. Groot, van der Harst, E., de Hingh, I. H. J. T., Kazemier, G., Liem, M. S. L., Meijer, G., de Meijer, V. E., Nieuwenhuijs, V. B., Roos, D., Schreinemakers, J. M. J., Stommel, M. W. J., Wit, F., Verdonk, R. C., van Santvoort, H. C., Molenaar, I. Q., Intven, M. P. W., and Daamen, L. A.

Published
2024
Full Text
View/download PDF

2. Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design

Author

Daamen, L. A., van Goor, I. W. J. M., Groot, V. P., Andel, P. C. M., Brosens, L. A. A., Busch, O. R., Cirkel, G. A., Mohammad, N. Haj, Heerkens, H. D., de Hingh, I. H. J. T., Hoogwater, F., van Laarhoven, H. W. M., Los, M., Meijer, G. J., de Meijer, V. E., Pande, R., Roberts, K. J., Stoker, J., Stommel, M. W. J., van Tienhoven, G., Verdonk, R. C., Verkooijen, H. M., Wessels, F. J., Wilmink, J. W., Besselink, M. G., van Santvoort, H. C., Intven, M. P. W., and Molenaar, I. Q.

Published
2024
Full Text
View/download PDF

3. Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design

Author

Daamen, L. A., van Goor, I. W. J. M., Groot, V. P., Andel, P. C. M., Brosens, L. A. A., Busch, O. R., Cirkel, G. A., Mohammad, N. Haj, Heerkens, H. D., de Hingh, I. H. J. T., Hoogwater, F., van Laarhoven, H. W. M., Los, M., Meijer, G. J., de Meijer, V. E., Pande, R., Roberts, K. J., Stoker, J., Stommel, M. W. J., van Tienhoven, G., Verdonk, R. C., Verkooijen, H. M., Wessels, F. J., Wilmink, J. W., Besselink, M. G., van Santvoort, H. C., Intven, M. P. W., and Molenaar, I. Q.

Published
2024
Full Text
View/download PDF

4. Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial

Author

Bakkers, C., Rovers, K. P., Rijken, A., Simkens, G. A. A. M., Bonhof, C. S., Nienhuijs, S. W., Burger, J. W. A., Creemers, G. J. M., Brandt-Kerkhof, A. R. M., Tuynman, J. B., Aalbers, A. G. J., Wiezer, M. J., de Reuver, P. R., van Grevenstein, W. M. U., Hemmer, P. H. J., Punt, C. J. A., Tanis, P. J., Mols, F., and de Hingh, I. H. J. T.

Published
2023
Full Text
View/download PDF

8. ASO Visual Abstract: Short- and Long-Term Outcomes of Pancreatic Cancer Resection for Elderly Patients: A Nationwide Analysis

Author

Henry, A. C., Schouten, T. J., Daamen, L. A., Walma, M. S., Noordzij, P., Cirkel, G. A., Los, M., Besselink, M. G., Busch, O. R., Bonsing, B. A., Bosscha, K., van Dam, R. M., Festen, S., Groot Koerkamp, B., van der Harst, E., de Hingh, I. H. J. T., Kazemier, G., Liem, M. S., de Meijer, V. E., Nieuwenhuijs, V. B., Roos, D., Schreinemakers, J. M. J., Stommel, M. W. J., Molenaar, I. Q., and van Santvoort, H. C.

Published
2022
Full Text
View/download PDF

10. Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial

Author

Engbersen, M. P., Rijsemus, C. J. V., Nederend, J., Aalbers, A. G. J., de Hingh, I. H. J. T., Retel, V., Lambregts, D. M. J., Van der Hoeven, E. J. R. J., Boerma, D., Wiezer, M. J., De Vries, M., Madsen, E. V. E., Brandt-Kerkhof, A. R. M., Van Koeverden, S., De Reuver, P. R., Beets-Tan, R. G. H., Kok, N. F. M., and Lahaye, M. J.

Published
2021
Full Text
View/download PDF

12. Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial

Author

Hop, W C, Opmeer, B C, Reitsma, J B, Scholte, R A, Waltmann, E W H, Legemate, D A, Bartelsman, J F, Meijer, D W, de Brouwer, M, van Dalen, J, Durbridge, M, Geerdink, M, Ilbrink, G J, Mehmedovic, S, Middelhoek, P, Di Saverio, Salomone, Boom, M J, Consten, E C J, van der Bilt, J D W, van Olden, G D J, Stam, M A W, Verweij, M S, Busch, O R C, Buskens, C J, El-Massoudi, Y, Kluit, A B, van Rossem, C C, Schijven, M P, Tanis, P J, Unlu, C, Gerhards, M F, Karsten, T M, de Nes, L C, Rijna, H, van Wagensveld, B A, Koffeman, G I, Steller, E P, Tuynman, J B, Bruin, S C, van der Peet, D L, Blanken-Peeters, C F J M, Cense, H A, Jutte, E, Crolla, R M P H, van der Schelling, G P, van Zeeland, M, de Graaf, E J R, Groenendijk, R P R, Vermaas, M, Schouten, O, de Vries, M R, Prins, H A, Lips, D J, Bosker, R J I, van der Hoeven, J A B, Diks, J, Plaisier, P W, Kruyt, P M, Sietses, C, Stommel, M W J, Nienhuijs, S W, de Hingh, I H J T, Luyer, M D P, van Montfort, G, Ponten, E H, Smulders, J F, van Duyn, E B, Klaase, J M, Swank, D J, Ottow, R T, Stockmann, H B A C, Vermeulen, J, Vuylsteke, R J C L M, Belgers, H J, Fransen, S, von Meijenfeldt, E M, Sosef, M N, van Geloven, A A W, Hendriks, E R, ter Horst, B, Leeuwenburgh, M M N, van Ruler, O, Vogten, J M, Vriens, E J C, Westerterp, M, Eijsbouts, Q A J, Bentohami, A, Bijlsma, T S, de Korte, N, Nio, D, Govaert, M J P M, Joosten, J J A, Tollenaar, R A E M, Stassen, L P S, Wiezer, M J, Hazebroek, E J, Smits, A B, van Westreenen, H L, Lange, J F, Brandt, A, Nijboer, W N, Toorenvliet, B R, Weidema, W F, Coene, P P L O, Mannaerts, G H H, den Hartog, D, de Vos, R J, Zengerink, J F, Hoofwijk, A G M, Hulsewé, K W E, Melenhorst, J, Stoot, J H M B, Steup, W H, Huijstee, P J, Merkus, J W S, Wever, J J, Maring, J K, Heisterkamp, J, van Grevenstein, W M U, Vriens, M R, Besselink, M G H, Borel Rinkes, I H M, Witkamp, A J, Slooter, G D, Konsten, J L M, Engel, A F, Pierik, E G J M, Frakking, T G, van Geldere, D, Patijn, G A, D'Hoore, A J L, de Buck van Overstraeten, A, Miserez, M, Terrasson, I, Wolthuis, A, De Blasiis, M G, Vennix, Sandra, Musters, Gijsbert D, Mulder, Irene M, Swank, Hilko A, Consten, Esther C, Belgers, Eric H, van Geloven, Anna A, Gerhards, Michael F, Govaert, Marc J, van Grevenstein, Wilhelmina M, Hoofwijk, Anton G, Kruyt, Philip M, Nienhuijs, Simon W, Boermeester, Marja A, Vermeulen, Jefrey, van Dieren, Susan, Lange, Johan F, and Bemelman, Willem A

Published
2015
Full Text
View/download PDF

25. Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment

Author

Govaerts, K, Lurvink, R J, de Hingh, I H J T, Van der Speeten, K, Villeneuve, L, Kusamura, S, Kepenekian, V, Deraco, M, Glehen, O, Moran, B J, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M, Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W, Mohamed, Faheez, Morris, David L, Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A, et al, University of Zurich, and Govaerts, K

Subjects
Oncology, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021

26. The delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma

Author

Lurvink, R J, Villeneuve, L, Govaerts, K, de Hingh, I H J T, Moran, B J, Deraco, M, Van der Speeten, K, Glehen, O, Kepenekian, V, Kusamura, S, Alyami, Mohammad S, André, Thierry, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Bhatt, Aditi, Ben-Yaacov, Almog, Bertulli, Rosella, Braess, Jan, Burger, Jacobus W A, Cascales-Campos, Pedro, Cashin, Peter, Cecil, P, Tom, Ceelen, Wim P, Creemers, Geert-Jan, Cortes-Guiral, Delia, Dayal, Sanjeev, De Simone, Michele, Di Bartolomeo, Maria, Dube, Pierre, Flatmark, Kjersti, et al, University of Zurich, and Kusamura, S

Subjects
Delphi consensus, GRADE system, Oncology, Peritoneal mesothelioma, Peritoneal surface malignancies, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, Pseudomyxoma peritonei, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021

27. Peritoneal Mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up

Author

Kusamura, S, Kepenekian, V, Villeneuve, L, Lurvink, R J, Govaerts, K, De Hingh, I H J T, Moran, B J, Van der Speeten, K, Deraco, M, Glehen, O, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M, Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W, Mohamed, Faheez, Morris, David L, Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A, et al, University of Zurich, and Deraco, M

Subjects
Oncology, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021

28. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial):study protocol for a nationwide multicenter randomized controlled trial

Author

Janssen, Q. P., van Dam, J. L., Bonsing, B. A., Bos, H., Bosscha, K. P., Coene, P. P. L. O., van Eijck, C. H. J., de Hingh, I. H. J. T., Karsten, T. M., van der Kolk, M. B., Patijn, G. A., Liem, M. S. L., van Santvoort, H. C., Loosveld, O. J. L., De Vos-Geelen, J., Zonderhuis, B. M., Homs, M. Y., van Tienhoven, G., Besselink, M. G., Wilmink, J. W., Koerkamp, B. Groot, Janssen, Q. P., van Dam, J. L., Bonsing, B. A., Bos, H., Bosscha, K. P., Coene, P. P. L. O., van Eijck, C. H. J., de Hingh, I. H. J. T., Karsten, T. M., van der Kolk, M. B., Patijn, G. A., Liem, M. S. L., van Santvoort, H. C., Loosveld, O. J. L., De Vos-Geelen, J., Zonderhuis, B. M., Homs, M. Y., van Tienhoven, G., Besselink, M. G., Wilmink, J. W., and Koerkamp, B. Groot

Abstract

BackgroundNeoadjuvant therapy has several potential advantages over upfront surgery in patients with localized pancreatic cancer; more patients receive systemic treatment, fewer patients undergo futile surgery, and R0 resection rates are higher, thereby possibly improving overall survival (OS). Two recent randomized trials have suggested benefit of neoadjuvant chemoradiotherapy over upfront surgery, both including single-agent chemotherapy regimens. Potentially, the multi-agent FOLFIRINOX regimen (5-fluorouracil with leucovorin, irinotecan, and oxaliplatin) may further improve outcomes in the neoadjuvant setting for localized pancreatic cancer, but randomized studies are needed. The PREOPANC-2 trial investigates whether neoadjuvant FOLFIRINOX improves OS compared with neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine in resectable and borderline resectable pancreatic cancer patients.MethodsThis nationwide multicenter phase III randomized controlled trial includes patients with pathologically confirmed resectable and borderline resectable pancreatic cancer with a WHO performance score of 0 or 1. Resectable pancreatic cancer is defined as no arterial and <= 90 degrees venous involvement; borderline resectable pancreatic cancer is defined as <= 90 degrees arterial and <= 270 degrees venous involvement without occlusion. Patients receive 8cycles of neoadjuvant FOLFIRINOX chemotherapy followed by surgery without adjuvant treatment (arm A), or 3cycles of neoadjuvant gemcitabine with hypofractionated radiotherapy (36Gy in 15 fractions) during the second cycle, followed by surgery and 4cycles of adjuvant gemcitabine (arm B). The primary endpoint is OS by intention-to-treat. Secondary endpoints include progression-free survival, quality of life, resection rate, and R0 resection rate. To detect a hazard ratio of 0.70 with 80% power, 252 events are needed. The number of events is expected to be reached after inclusion of 368 eligible patients as

Published
2021

29. Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial

Author

Engbersen, M P, Rijsemus, C J V, Nederend, J, Aalbers, A G J, de Hingh, I H J T, Retel, V, Lambregts, D M J, Van der Hoeven, E J R J, Boerma, D, Wiezer, M J, De Vries, M, Madsen, E V E, Brandt-Kerkhof, A R M, Van Koeverden, S, De Reuver, P R, Beets-Tan, R G H, Kok, N F M, Lahaye, M J, Engbersen, M P, Rijsemus, C J V, Nederend, J, Aalbers, A G J, de Hingh, I H J T, Retel, V, Lambregts, D M J, Van der Hoeven, E J R J, Boerma, D, Wiezer, M J, De Vries, M, Madsen, E V E, Brandt-Kerkhof, A R M, Van Koeverden, S, De Reuver, P R, Beets-Tan, R G H, Kok, N F M, and Lahaye, M J

Abstract

BACKGROUND: Selecting patients with peritoneal metastases from colorectal cancer (CRCPM) who might benefit from cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is challenging. Computed tomography generally underestimates the peritoneal tumor load. Diagnostic laparoscopy is often used to determine whether patients are amenable for surgery. Magnetic resonance imaging (MRI) has shown to be accurate in predicting completeness of CRS. The aim of this study is to determine whether MRI can effectively reduce the need for surgical staging.METHODS: The study is designed as a multicenter randomized controlled trial (RCT) of colorectal cancer patients who are deemed eligible for CRS-HIPEC after conventional CT staging. Patients are randomly assigned to either MRI based staging (arm A) or to standard surgical staging with or without laparoscopy (arm B). In arm A, MRI assessment will determine whether patients are eligible for CRS-HIPEC. In borderline cases, an additional diagnostic laparoscopy is advised. The primary outcome is the number of unnecessary surgical procedures in both arms defined as: all surgeries in patients with definitely inoperable disease (PCI > 24) or explorative surgeries in patients with limited disease (PCI < 15). Secondary outcomes include correlations between surgical findings and MRI findings, cost-effectiveness, and quality of life (QOL) analysis.CONCLUSION: This randomized trial determines whether MRI can effectively replace surgical staging in patients with CRCPM considered for CRS-HIPEC.TRIAL REGISTRATION: Registered in the clinical trials registry of U.S. National Library of Medicine under NCT04231175 .

Published
2021

45. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer

Author

Schaap, D P, primary, Valk, K S, additional, Deken, M M, additional, Meijer, R P J, additional, Burggraaf, J, additional, Vahrmeijer, A L, additional, Kusters, M, additional, Boogerd, L S F, additional, Schaap, D P, additional, Voogt, E L K, additional, Nieuwenhuijzen, G A P, additional, Rutten, H J T, additional, de Hingh, I H J T, additional, Burger, J W A, additional, Nienhuijs, S W, additional, de Valk, K S, additional, Brandt-Kerkhof, A R M, additional, Verhoef, C, additional, Madsen, E V E, additional, van Kooten, J P, additional, Framery, B, additional, Gutowski, M, additional, PM-hlegrin, A, additional, Cailler, F, additional, van Lijnschoten, I, additional, and Hoogstins, C E S, additional

Published
2020
Full Text
View/download PDF

48. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

Author

Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T., Rovers, K. P., van Grevenstein, W. M. U., Lacle, M. M., Kops, G. J. P. L., Rinkes, I. H. M. Borel, Kranenburg, O., Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T., Rovers, K. P., van Grevenstein, W. M. U., Lacle, M. M., Kops, G. J. P. L., Rinkes, I. H. M. Borel, and Kranenburg, O.

Published
2019

49. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

Author

MS CGO, Cancer, Epi Kanker Team A, JC onderzoeksprogramma Kanker, Regenerative Medicine and Stem Cells, Zorgeenheid Heelkunde Medisch, Pathologie Pathologen staf, Hubrecht Institute with UMC, CMM Sectie Molecular Cancer Research, CMM Groep Coffer, Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T., Rovers, K. P., van Grevenstein, W. M. U., Lacle, M. M., Kops, G. J. P. L., Rinkes, I. H. M. Borel, Kranenburg, O., MS CGO, Cancer, Epi Kanker Team A, JC onderzoeksprogramma Kanker, Regenerative Medicine and Stem Cells, Zorgeenheid Heelkunde Medisch, Pathologie Pathologen staf, Hubrecht Institute with UMC, CMM Sectie Molecular Cancer Research, CMM Groep Coffer, Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T., Rovers, K. P., van Grevenstein, W. M. U., Lacle, M. M., Kops, G. J. P. L., Rinkes, I. H. M. Borel, and Kranenburg, O.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results